COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Sean McCarthy will participate on a panel at the Charlotte Biotechnology Conference titled "Financing Successful Biotech Companies", on the campus of UNC-Charlotte.
News | 10. 12. 2007
